Safety and feasibility of minimally invasive lobectomy after neoadjuvant immunotherapy for non–small cell lung cancer is a research paper published in Journal of Thoracic and Cardiovascular Surgery (2022). On theSindex it has a DataRank of 0.449. It has been cited 19 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.449
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: 5T32CA092203
National Institutes of Health
Grant: 1R01HL159170-01A1
Using Wearable Technology to Assess Recovery and Detect Post-Operative Complications Following Cardiothoracic Surgery
NCI NIH HHS
Grant: T32 CA092203
NHLBI NIH HHS
Grant: R01 HL159170
FWCI
1.77
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals